“Something happens in your brain on the medication. You eat only when you’re hungry, and you stop when you’re full. I couldn’t believe it. This is what it’s like to be free from the constant pull of food, I realized. Free from the constant chatter in your head about what to eat, how much to eat, how much you just ate, how many calories it cost you, and what it’s going to take to burn off those calories. An aperture had opened in my mind—I saw new possibilities. And I see them now every day. I say yes to life.”

Winfrey explains how taking obesity medications has helped her experience a new sense of freedom by making her feel full and satisfied after she has eaten. Her personal experience echoes that of many people who have obesity and experience the same “food noise” that clouds their thinking. Winfrey does not address how diet culture and beauty ideals of thinness may have contributed to her fixation on “calories” and the “constant chatter” that distorted her relationship with food.

“It turns out that our environment changed much more quickly than our biology evolved. The environment we live in is filled with ultra-processed food, lack of sleep, lack of physical activity, and a lot of stress. This environment promotes the storage of extra energy, and we respond by doing just that—storing extra energy, extra fuel.”

Dr. Ania Jastreboff adds to the book’s theme on The Biology of Obesity by arguing that our modern food and lifestyles are actually “obesogenic,” or obesity causing. In insisting that obesity is a “disease” caused by “biology,” however, Jastreboff tends to sidestep serious engagement with modern external factors that have been noted to contribute to weight and health issues, such as food insecurity and poverty (See: Background).

“I think now of the hours and hours and days and years of wasted time and energy I’ve devoted to losing and gaining weight, and how truly astonishing it is to learn, after all these years of blaming myself for the failure, that it is not and never was about willpower. That it’s about your brain—and how your brain is going to fight to get you back to the weight that you were trying to lose.”

Winfrey recalls the enormous effort and focus she put into losing weight over the course of decades, speaking to the theme of obesity as a disease versus personal failure. This passage endorses Jastreboff’s claim that people with obesity cannot use willpower alone to solve their problem, but once again, she does not address why such emphasis is placed on thinness and appearance in matters of self-worth and health in the first place.

“This is the disease of obesity. And quite honestly, if we were living during a famine, a time of scarcity, people with obesity would have an advantage. Their brains’ pull to store more energy would better protect them against starvation. But in our modern world, in an environment that encourages storing extra energy, there has been a shift in how much fat all of us store.”

Jastreboff acknowledges the role that genetics plays in fostering obesity in the body, arguing for the biology of obesity. She claims that people whose ancestors evolved to effectively store fat are now at a disadvantage in the modern world, as this trait makes them predisposed to experiencing obesity. However, Jastreboff’s definition of obesity as a biological phenomenon is not a matter of consensus in the medical community but one theory among many.

“Self-blame manifests as that mean inner voice. ‘It’s no one’s fault but my own that I gained weight,’ the voice says. The guilt piles on. The cycle becomes self-reinforcing: Blame leads to shame, and shame leads to self-blame, which then fuels self-shame. And because the voice is internal, it often feels inescapable.”

Jastreboff laments how so many people with obesity develop problems with self-worth and self-image because of their “failure” to lose weight and keep it off. She claims to want to combat self-shame and negative feelings in people with higher weight, but her insistence that being larger is always an issue reinforces stigma around weight and larger bodies.

“As a physician specializing in the care of people with obesity, I consider that obesity is a disease where the weight-controlling regions of the brain inappropriately instruct the body to store more fat than is healthy or needed. This occurs in the setting of our obesogenic environment.”

The author’s definition of obesity does not include people’s behavior but instead focuses on the biological processes at work in the body. Jastreboff argues for the biology of obesity, but her phrasing here—“I consider that obesity is a disease”—elides the fact that her “disease” theory is not yet considered a medical fact. Her acknowledgement of the “obesogenic environment” of modern life also gestures toward external, non-biological factors while not fully considering how those non-biological factors complicate the idea of obesity as a biological phenomenon.

“Humans evolved to survive scarcity: bodies built to store energy, brains wired to seek calorie-dense food, muscles designed for constant movement…Our bodies were never meant to exist in a world of ultra-processed foods, desk jobs, no respect for rest or sleep, endless screens and pings, and stressful commutes.”

Jastreboff contrasts the environments that our ancestors evolved in with our modern-day lives of constant access to food and sedentary, yet stressful, lifestyles. This evolutionary perspective illuminates why the human body is currently struggling to appropriately store fat, adding to the book’s theme on the biology of obesity. Jastreboff does not advocate for addressing any of these systemic factors, however, choosing instead to promote GLP-1s as the only viable solution.

“I still have the check I wrote to my first diet doctor—Baltimore, 1977, I was twenty-three years old, 148 pounds, a size 8, and I thought I was fat. The doctor put me on a 1,200-calorie regimen, and in less than two weeks I had lost ten pounds (there’s nothing like the first time…). Two months later, I’d regained twelve. That was the beginning of the cycle of discontent, the struggle with my body. With myself.”

Winfrey recalls how she began her cycle of dieting, losing weight, and regaining weight as a young adult. Her memories about her “cycle of discontent” personalize Jastreboff’s insights about the mental-health strain that many people with obesity experience. Winfrey does not address whether diet culture is the real culprit and instead promotes a new way of getting a thinner body.

“The Enough Point describes the brain’s intention. The brain is working to maintain a state of equilibrium relative to the amount of energy it thinks the body should store. It’s working to ensure we have the fuel and energy it predicts we will need. It’s trying to protect us in the best way it knows how. But remember, our environment has recently changed to be obesogenic. This environment confuses our brain into thinking there is not enough fat in our bodies.”

Jastreboff adds to the book’s theme on the biology of obesity by explaining how the brain becomes confused about how much energy to store as fat. By portraying obesity as the result of a confused brain-body feedback loop, the author redirects readers’ attention from people’s personal choices and illuminates the body’s inner processes instead. She once again acknowledges the “obesogenic” environment but does not seriously consider how that environment could be changed to promote better health for individuals and societies.

“This study demonstrated that as we lose weight, our bodies’ hormones respond in a way that promotes more food intake. So, as we lose more and more weight, our bodies fight back, releasing every signal that they can, to make sure we replenish energy stores. Collectively, we call these changes ‘metabolic adaptation.’”

Metabolic adaptation plays a key role in obesity. By describing how our bodies’ hormonal systems work to promote eating and therefore fat storage, the author presents it as foundational to the biology of obesity.

“Hormones are the key messengers in the obesity story because they are important in helping to determine both the time and scale of a meal and the food consumed. They are also the longer-term regulators of how our bodies manage our Enough Point, and so that’s why we’re going to focus on hormones.”

Jastreboff points to hormones as the “messengers” that relay information from the body to the brain. This explanation provides readers with the necessary information to understand how obesity medications, which are synthetic hormones, work in the body. It also sets up the author’s argument for The Medical Necessity of Treating Obesity, as she will promote GLP-1s as the solution to the “Enough Point” problem.

“The weight-controlling regions of the brain become increasingly frustrated. All of this discussion between her body and brain results in hormonal signaling—making her want to increase energy intake, perhaps by increasing cravings for energy-dense foods—because her body thinks it is starving.”

The author describes the biology of obesity by showing how the body’s cues affect people mentally, with the author portraying obesity as a condition that wrongly prompts people to overeat. Her use of the words “cravings” and “starving” presents these cues as powerful and unignorable, adding to her argument that obesity cannot be resolved through willpower alone.

“For many people with obesity, food noise is unrelenting. That’s why, over the long term, the executive regions of the brain don’t stand a chance against the onslaught of minute-to-minute hormone signals that are howling for attention. The feedback loops (from chapter 3) are incredibly powerful, wired for survival, and not in our conscious control.”

Jastreboff characterizes food noise as “unrelenting,” emphasizing the body’s insistence that people eat more food and regain their fat stores. By again offering a window into these processes, Jastreboff illuminates the complex inner world of the human body, arguing for obesity as a disease versus personal failure.

“But it’s nearly impossible to reach for all these other goals when your attention is constantly pulled back to managing calories, cravings, and hunger. When every spare thought is hijacked by food. That’s the cost of the cognitive load. You can’t outthink or out-dream biology. As my colleague Dr. Lee Kaplan once summed it up: ‘Overeating does not cause obesity; obesity causes overeating.’ Bottom line, biology drives behavior.”

Jastreboff explores how food noise burdens obese people with a heavy “cognitive load,” as they wrestle with cravings. Her colleague’s quote endorses her view that biology is a powerful driver of behavior, but she does not acknowledge or address the research linking weight and health to socioeconomic and environmental factors.

“The parade of various remedies—from vinegar drafts to rainbow pills—reads like a cautionary tale. But during much of this time, the science of obesity was not well understood, and therefore the biology could not be targeted. The desire to lose weight was there, but not the understanding of the disease of obesity or how to treat it.”

Jastreboff continues her discussion of obesity as a disease versus personal failure by acknowledging the unsuccessful history of obesity medications, from ancient times to the recent past. This passage distinguishes old obesity medications from new ones by claiming that today’s scientific understanding of obesity is superior to that of the past and therefore that the new medications will be more effective. Jastreboff also criticizes older medications elsewhere for their serious side effects but does not consider the potential side effects of GLP-1s as a disqualification.

“Some people lose a lot of weight with the new medications, whereas others will lose no weight at all. That’s why your sister may have lost fifty pounds with one of the medicines, but your cousin lost ten pounds with the same medicine.”

Jastreboff acknowledges the unpredictable discrepancies in how people actually experience obesity medications. This passage reminds the readers that while these medications do tend to prompt weight loss, it is impossible to know by how much, suggesting that more research must be done for the medications to become more predictable. The widely varying results, including some very poor ones—“others will lose no weight at all”—raises the question as to why Jastreboff would promote these GLP-1s as a solution when, for many, they will not work at all as intended.

“Early on in the shortage, the issue wasn’t that there was not enough semaglutide; it was that there was insufficient semaglutide in the single-dose injector devices. The medication shortages lasted until 2024 for tirzepatide and 2025 for semaglutide. Seeing patients regain fifty, sixty, eighty pounds after losing access to a medication, whether due to a shortage or loss of insurance coverage, was and continues to be egregious and heartbreaking.”

Jastreboff laments that people’s experiences on these medications has been marred by their lack of continued access to them, whether from shortages or insurance problems. She uses emotive language such as “heartbreaking” to evoke pathos in the readers and present her outrage as altruistic.

“Down the road, there will be many other new medications that target different NuSH receptors, like amylin, PYY, and glucagon receptors. These new NuSH-based medications will be very useful, because targeting different receptors allows us to treat different biological mechanisms, thus hopefully different types of obesities and obesity-related conditions.”

Jastreboff hopes that obesity medications will continue to become more effective and more specifically prescribed, promoting the medical necessity of treating obesity. This passage acknowledges that the research is ongoing, capturing Jastreboff’s hope for the future while also admitting that this branch of medicine is in its infancy, which calls into question her confident pronouncements on the efficacy of GLP-1s.

“This why question is crucial. It tells me what they care about in life—and what they care about will help them stick to whatever plan we develop. Their answers will help keep them motivated as we move toward their goals: their goals, because it’s their life.”

Jastreboff’s approach to patient-centered care empowers people to form their own visions for the future and goals for their physical and mental health. This discussion humanizes people with obesity and advances Jastreboff’s argument that each person should decide for themselves, without guilt or shame, what they would like their body to look and feel like. Her insistence that obesity is a disease and that everyone should aim for a smaller body, however, could be seen as contradicting this empowering rhetoric.

“If a person decides to start taking medications, it is key to pair those medications with healthful eating and physical activity. Nutritious food fuels our bodies. Exercise has health benefits that go well beyond weight maintenance: strength, muscles, bone health, mood, and the way our body uses fuel, especially glucose. We need to reimagine the goal of lifestyle changes—it’s not about a number or weight. Instead, it’s about optimizing health.”

Jastreboff widens her conversation about weight loss, pointing to lifestyle changes as another key component of using obesity medications. Her acknowledgement here of the importance of “healthful eating and physical activity” somewhat contradicts her earlier assertion that relying on willpower is a dead end for weight loss.

“The point is, you don’t need to be ‘perfect’ all the time (‘perfection is the enemy of good’ and not realistic or attainable)—let’s just pick the middle choice. The goal is not to feel deprived but rather to choose foods that fuel your body and give you energy. Additionally, it’s the consistent small changes that make a difference over time, not the all-or-nothing changes that we make once in a while.”

Jastreboff’s approach focuses on realistic choices instead of extreme cleanses or diets. By choosing “middle” foods, she argues, people with obesity will integrate more healthful foods into their lives without stressing about attaining “perfection” or engaging in yo-yo diets. Her emphasis on the importance of diet once again raises questions about why GLP-1s are so necessary when lifestyle changes are required anyway.

“Their brain gets the signal that they have more than enough energy stores. Their body is chasing their new Enough Point, lowered by the medication. This is important, so I’m going to state it again—their body is chasing a new, lower Enough Point. Therefore, they have little interest in food and eat very little, especially in comparison to what they may have been used to eating before.”

Jastreboff reiterates how obesity medications change people’s brains and body cues. By forcibly lowering people’s Enough Point, the medications produce feelings of satiety and redirect people’s focus from food and cravings to other aspects of their lives.

“All medications for any disease have ‘on-target’ and ‘off-target’ effects, meaning there are desirable benefits and some less-than-desirable ones…The undesirable effects, such as gastrointestinal side effects, if they arise, tend to go away once the swings in the concentration of the medicine in our body start to level off.”

Jastreboff acknowledges that some people experience irritating or even harmful side effects after using obesity medications but tends to downplay them (See: Background). By discussing these “off-target” effects, the author acknowledges that everyone experiences them differently, but the example she gives here, “gastrointestinal side effects,” keeps the focus on more mild side effects.